相似文献
1
Parathyroidectomy: Complex Decisions about a Complex Procedure.
Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1133-1135. doi: 10.2215/CJN.04950516. Epub 2016 Jun 6.
2
Preoperative imaging of parathyroid glands with technetium-99m-labelled sestamibi and iodine-123 subtraction scanning in secondary hyperparathyroidism.
Lancet. 1999 Jun 26;353(9171):2200-4. doi: 10.1016/S0140-6736(98)09089-8.
3
Surgical treatment of renal hyperparathyroidism.
Semin Surg Oncol. 1997 Mar-Apr;13(2):87-96. doi: 10.1002/(sici)1098-2388(199703/04)13:2<87::aid-ssu4>3.0.co;2-y.
4
Pedicled parathyroid gland autotransposition in secondary and tertiary hyperparathyroidism.
Laryngoscope. 2015 Apr;125(4):894-7. doi: 10.1002/lary.24962. Epub 2014 Oct 7.
5
6
Surgical anatomy of the parathyroid glands in secondary hyperparathyroidism.
J R Coll Surg Edinb. 1998 Aug;43(4):271-3.
7
Critical analysis of the intraoperative parathyroid hormone decrease during parathyroidectomy for secondary and tertiary hyperparathyroidism.
Surgery. 2020 Dec;168(6):1079-1085. doi: 10.1016/j.surg.2020.06.043. Epub 2020 Aug 15.
8
[Exploration on total parathyroidectomy for secondary hyperparathyroidism].
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020 Feb 7;55(2):98-103. doi: 10.3760/cma.j.issn.1673-0860.2020.02.004.
9
[Intraoperative parathyroid hormone monitoring in neck exploration for renal hyperparathyroidism?].
Chirurg. 2002 Mar;73(3):211-6. doi: 10.1007/s00104-001-0387-z.
10
Parathyroidectomy-A last resort for hyperparathyroidism in dialysis patients.
Semin Dial. 2017 Sep;30(5):385-389. doi: 10.1111/sdi.12632. Epub 2017 Jul 5.
引用本文的文献
1
Parathyroidectomy: is vitamin D a player for a good outcome?
J Med Life. 2016 Oct-Dec;9(4):348-352.
本文引用的文献
1
Rates and Outcomes of Parathyroidectomy for Secondary Hyperparathyroidism in the United States.
Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1260-1267. doi: 10.2215/CJN.10370915. Epub 2016 Jun 6.
2
Dynamics of cinacalcet use and biochemical control in hemodialysis patients: a retrospective New-user cohort design.
BMC Nephrol. 2015 Oct 29;16:175. doi: 10.1186/s12882-015-0174-6.
3
Changes in secondary hyperparathyroidism-related biochemical parameters and medication use following parathyroidectomy.
Nephrol Dial Transplant. 2016 Jan;31(1):103-11. doi: 10.1093/ndt/gfv291. Epub 2015 Aug 19.
4
Peer kidney care initiative 2014 report: dialysis care and outcomes in the United States.
Am J Kidney Dis. 2015 Jun;65(6 Suppl 1):Svi, S1-140. doi: 10.1053/j.ajkd.2015.03.021.
5
A randomized, double-blind, phase 2 study evaluating the safety and efficacy of AMG 416 for the treatment of secondary hyperparathyroidism in hemodialysis patients.
Curr Med Res Opin. 2015 May;31(5):943-52. doi: 10.1185/03007995.2015.1031731.
6
Clinical outcomes after parathyroidectomy in a nationwide cohort of patients on hemodialysis.
Clin J Am Soc Nephrol. 2015 Jan 7;10(1):90-7. doi: 10.2215/CJN.03520414. Epub 2014 Dec 16.
7
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients.
Cochrane Database Syst Rev. 2014;2014(12):CD006254. doi: 10.1002/14651858.CD006254.pub2. Epub 2014 Dec 9.
8
Trends in the frequency and quality of parathyroid surgery: analysis of 17,082 cases over 10 years.
Ann Surg. 2015 Apr;261(4):746-50. doi: 10.1097/SLA.0000000000000812.
9
AMG 416 (velcalcetide) is a novel peptide for the treatment of secondary hyperparathyroidism in a single-dose study in hemodialysis patients.
Kidney Int. 2014 Jan;85(1):191-7. doi: 10.1038/ki.2013.289. Epub 2013 Jul 31.
10
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.
N Engl J Med. 2012 Dec 27;367(26):2482-94. doi: 10.1056/NEJMoa1205624. Epub 2012 Nov 3.
Zotero 插件